1. Jennett B, Teasdale
G. Management of head injuries. Philadelphia: FA Davies, 1981.
2. Jennett B, Bond M. Assessment of outcome after severe brain damage.
Lancet 1975;1: 480-4.
3. Alderson P, Roberts I. Kortikosteroidy in acute traumatic brain injury:
systematic review of randomised controlled trials. BMJ 1997;314:1855-9.
4. Bracken MB, Shepard MJ, Collins WF, et al. A randomised controlled
trial of methylprednisolone or naloxone in the treatment of acute spinal
cord injury. N Eng J Med 1990;322:1405-11.
5. Otani K, Abe H, Kadoya S, et al. Beneficial effect of methylprednisolone
sodium succinate in the treatment of acute spinal cord injury (translation
of Japanese). Sekitsui Sekizui J 1994;7:633-47.
6. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone
for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment
of acute spinal cord injury. Results of the Third National Acute Spinal
Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury
Study. JAMA 1997;277:1597-604
7. Demopoulos HB, Flamm ES, Seligman ML. Further studies on free radical
pathology in the major central nervous system disorders: effects of very
high doses of methylprednisolone on the functional outcome, morphology,
and chemistry of experimental spinal cord impact injury. Can J Physiol
Pharmacol 1982;60:1415-24.
8. Anderson DK, Saunders RD, Demediuk P. Lipid hydrolysis and peroxidation
in injured spinal cord: partial protection with methylprednisolone or
vitamin E and selenium. Central Nervous System Trauma 1985;2:257-67.
9. Braughler JM, Hall ED, Means ED, et al. Evaluation of an intensive
methylprednisolone sodium succinate dosing regimen in experimental spinal
cord injury. J Neurosurg 1987; 67: 102-5.
10. Hall ED. High dose glucocorticoid treatment improves neurological
recovery in head-injured mice. J Neurosurg 1985;62:882-7.
11. Hall ED. The neuroprotective pharmacology of methylprednisolone. J.
Neurosurg 1992;76:13-22.
12. Gaab MR, Trost HA, Alcantara A, et al. Ultrahigh dexamethasone in
acute brain injury. Results from a prospective randomised double-blind
multi-centre trial. Zentralblatt für Neurochirurgie 1994;55:135-43.
13. Collins R, Doll R, Peto R. Ethics of clinical trials. In: Williams
C, ed. Introducing New Treatments for Cancer. Chichester: John Wiley and
Sons Ltd, 1991.
14. Ewan PW. Treatment of anaphylactic reactions. Prescribers' Journal
1997;37:125-32.
15. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomised
clinical trials requiring prolonged observation of each patient.
1. Introduction and design. Br J Cancer 1976;34:585-612.
|